Submitted by Anonymous (not verified) on 14 September 2026 - 14:47
Human medicines European public assessment report (EPAR): Abrysvo, respiratory syncytial virus vaccine (bivalent, recombinant), Date of authorisation: 23/08/2023, Revision: 17, Status: Authorised
Source: